1. Home
  2. FGI vs GLTO Comparison

FGI vs GLTO Comparison

Compare FGI & GLTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FGI
  • GLTO
  • Stock Information
  • Founded
  • FGI 1987
  • GLTO 2011
  • Country
  • FGI United States
  • GLTO Denmark
  • Employees
  • FGI N/A
  • GLTO N/A
  • Industry
  • FGI Industrial Specialties
  • GLTO Biotechnology: Pharmaceutical Preparations
  • Sector
  • FGI Industrials
  • GLTO Health Care
  • Exchange
  • FGI Nasdaq
  • GLTO Nasdaq
  • Market Cap
  • FGI 8.0M
  • GLTO 6.5M
  • IPO Year
  • FGI 2022
  • GLTO 2020
  • Fundamental
  • Price
  • FGI $0.87
  • GLTO $4.81
  • Analyst Decision
  • FGI
  • GLTO Buy
  • Analyst Count
  • FGI 0
  • GLTO 1
  • Target Price
  • FGI N/A
  • GLTO $10.00
  • AVG Volume (30 Days)
  • FGI 5.1K
  • GLTO 14.7K
  • Earning Date
  • FGI 03-19-2025
  • GLTO 03-07-2025
  • Dividend Yield
  • FGI N/A
  • GLTO N/A
  • EPS Growth
  • FGI N/A
  • GLTO N/A
  • EPS
  • FGI N/A
  • GLTO N/A
  • Revenue
  • FGI $127,180,460.00
  • GLTO N/A
  • Revenue This Year
  • FGI $11.39
  • GLTO N/A
  • Revenue Next Year
  • FGI $6.26
  • GLTO N/A
  • P/E Ratio
  • FGI N/A
  • GLTO N/A
  • Revenue Growth
  • FGI 7.71
  • GLTO N/A
  • 52 Week Low
  • FGI $0.70
  • GLTO $4.24
  • 52 Week High
  • FGI $1.85
  • GLTO $23.50
  • Technical
  • Relative Strength Index (RSI)
  • FGI 52.94
  • GLTO 46.22
  • Support Level
  • FGI $0.81
  • GLTO $4.24
  • Resistance Level
  • FGI $0.90
  • GLTO $5.00
  • Average True Range (ATR)
  • FGI 0.04
  • GLTO 0.32
  • MACD
  • FGI -0.00
  • GLTO 0.01
  • Stochastic Oscillator
  • FGI 65.40
  • GLTO 51.35

About FGI FGI Industries Ltd.

FGI Industries Ltd is a supplier of kitchen and bath products. It offers sanitaryware, bath furniture, shower systems, customer kitchen cabinetry, and other accessory items. It is business to business supplier of bath and kitchen products to large retail, wholesale, commercial, and specialty channel customers around the globe. its revenue is generated by sanitaryware. Geographically it operates in the United States, Canada, Europe, Rest of the World, and the majority of its revenue comes from the United States.

About GLTO Galecto Inc.

Galecto Inc is a clinical-stage biotechnology company developing therapeutics designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer. Its initial focus is on the development of small-molecule inhibitors of galectin-3 and lysyl oxidase-like 2, or LOXL2. Its product candidate GB0139 is for the treatment of severe fibrotic lung diseases such as idiopathic pulmonary fibrosis, or IPF, a life-threatening progressive fibrotic disease of the lung. Its product GB1211, a selective oral galectin-3 inhibitor for the treatment of fibrosis related to non-alcoholic steatohepatitis, or NASH, and GB2064, a selective oral inhibitor of LOXL2 that it initially plans to develop for the treatment of myelofibrosis.

Share on Social Networks: